Arrowhead Pharmaceuticals Inc
LSE:0HI3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arrowhead Pharmaceuticals Inc
LSE:0HI3
|
US |
|
I
|
Independent Bank Corp (Michigan)
XBER:IB6A
|
US |
|
Daifuku Co Ltd
F:891
|
JP |
|
Inmobiliaria del Sur SA
LSE:0HFP
|
ES |
|
Suratwwala Business Group Ltd
BSE:543218
|
IN |
|
B
|
Bastei Luebbe AG
XMUN:BST
|
DE |
|
A
|
Arrail Group Ltd
F:I1D
|
CN |
|
T
|
Takashimaya Co Ltd
XMUN:TKM
|
JP |
|
T
|
Takashimaya Co Ltd
DUS:TKM
|
JP |
|
P
|
Pan American Silver Corp
F:PA2
|
CA |
|
T
|
Toll Brothers Inc
XMUN:TLK
|
US |
|
Haverty Furniture Companies Inc
F:25F0
|
US |
Shareholder Yield
Current shareholder yield for 
0HI3 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0HI3 Price
Arrowhead Pharmaceuticals Inc
| Average Annual Return | -24.33% |
| Standard Deviation of Annual Returns | 17.34% |
| Max Drawdown | -88% |
| Market Capitalization | 11.7B USD |
| Shares Outstanding | 9 812 929 107 |
| Percentage of Shares Shorted |
N/A
|
